...
首页> 外文期刊>Surgical infections >Infections and Use of Antibiotics in Patients Admitted for Severe Acute Pancreatitis: Data from the EPIC Ⅱ Study
【24h】

Infections and Use of Antibiotics in Patients Admitted for Severe Acute Pancreatitis: Data from the EPIC Ⅱ Study

机译:重症急性胰腺炎患者的感染和使用抗生素:来自EPICⅡ研究的数据

获取原文
获取原文并翻译 | 示例

摘要

Background: Infectious complications are frequent in severe acute pancreatitis (SAP) but multinational epi-demiologic data are lacking. The aim of the study was to analyze the characteristics of the infectious complications and antimicrobial use in this setting. Methods: One-day point prevalence study of infection in critically ill patients (Extended Prevalence of Infection in the ICU-Ⅱ study), performed in 1,265 ICUs in 75 countries. Results: Of the 13,796 patients in the study, 159 were admitted with SAP. One-hundred sixteen (73%) had infections: 31% intra-abdominal, 16% extra-abdominal, and 26% both. Gram-negative bacteria were more prevalent than gram-positive organisms, anaerobes, or fungi. Therapeutically, penicillins and other beta-lactams were used most frequently. Prophylactic antibiotics were administered to 24% of the patients with SAP. Conclusions: Infections are frequent in patients admitted with SAP; most are intra-abdominal infections. Microbiology is diverse with gram-negative micro-organisms most frequently isolated. Most patients admitted to the ICU for SAP receive antibiotics at some point.
机译:背景:严重急性胰腺炎(SAP)中感染并发症多发,但缺乏跨国流行病学数据。该研究的目的是分析这种情况下的感染并发症和抗菌药物的使用特征。方法:在75个国家/地区的1,265个ICU中进行了重症患者感染的一日流行率研究(ICU-Ⅱ研究中的扩展感染率)。结果:在研究的13796名患者中,有159名接受了SAP治疗。一百零六(73%)人感染:腹腔内感染率为31%,腹外感染率为16%,两者均为26%。革兰氏阴性细菌比革兰氏阳性生物,厌氧菌或真菌更为普遍。在治疗上,最常使用青霉素和其他β-内酰胺类药物。对24%的SAP患者使用了预防性抗生素。结论:SAP入院患者感染频繁。大多数是腹腔内感染。微生物种类繁多,最常分离的革兰氏阴性微生物。接受ICU接受SAP治疗的大多数患者在某些时候接受抗生素治疗。

著录项

  • 来源
    《Surgical infections 》 |2014年第4期| 394-398| 共5页
  • 作者单位

    Department of Critical Care Medicine, Ghent Medical School and University Hospital, Ghent, Belgium,Department of Critical Care Medicine Ghent University Hospital De Pintelaan 185 9000 Gent, Belgium;

    Critical Care Department, Hospital Vail d'Hebron, CIBERES, Universitat Autonoma de Barcelona, Spain;

    University of Texas Health Science Departments of Pulmonary/Critical Care, and Internal Medicine, and South Texas Veterans Health Care System, San Antonio, Texas;

    UCINC, Hospital de Sao Jose, Centro Hospitalar de Lisboa Central, Lisbon, Portugal;

    Discipline of Anesthesiology and Critical Care, The University of Queensland School of Medicine, and Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Herston QLD, Australia;

    Department of Anesthesiology and Intensive Care, Friedrich-Schiller-University, Jena, Germany;

    Department of Intensive Care, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands;

    Department of Intensive Care and Anesthesiology, Hopital Nord, AP-HM, Unite de Recherche en Maladies Infectieuses et Transmissibles (URMITE), Aix-Marseille University, Marseilles, France;

    Department of Intensive Care Medicine, Craigavon Area Hospital, Portadown, United Kingdom;

    Division of Pulmonary and Critical Care Medicine, Texas Tech University HSC, Odessa, Texas;

    Department of Intensive Care, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium;

  • 收录信息 美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号